Experimental findings show Δ-opioid receptor stimulation reduces apoptosis in neonatal cardiomyocytes, indicating potential therapeutic implications.
The aims of the present study were to determine whether Delta opioid receptor (δ-OR) stimulation improved the survival of cardiomyocytes cultured in serum-deprived conditions, which impaired their growth. [D-Ala2, D-Leu5]-enkephalin (DADLE), a selective δ-OR agonist, at a concentration range of 0.1 μmol/L to 10 μmol/L for 48 h increased the viability of the cardiomyocyte under serum deprivation conditions. DADLE (0.1 μmol/L) also decreased the early cell apoptosis rate and the expression of Caspase-3. The effects of 0.1 μmol/L DADLE were abolished by 10 μmol · L–1 naltrindole, a selective δ&OR antagonist, or by blockade of protein kinase C (PKC) with its blockers, 10 μmol · L–1 GF109203X or 1 μmol/L staurosporine. Furthermore, 0.1 μmol · L–1 DADLE increased the expression of PKC, an effect abrogated by 10 μmol · L–1 naltrindole. The observations indicate that δ-OR stimulation improves the viability and reduces the apoptosis via PKC pathway in neonatal cardiomyocytes cultured in serum deprived conditions.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: